Cambridge Raman Imaging selected to coordinate a European Union grant to transform cancer diagnosis and treatment
Cambridge Raman Imaging (CRI) has announced it was selected to coordinate a project that received a â¬3.3 million grant in the European Innovation Council’s (EIC) Transition call.
The project, called CHARM, aims to develop a medical device based on high-speed, low-cost Raman digital imaging technology and artificial intelligence to transform cancer diagnosis and treatment. The technology will analyze the molecular composition of patient tissue samples to distinguish cancerous from healthy cells without the need for chemical staining.